Cystoid macular edema in the era of ocular hypotensive lipids

American Journal of Ophthalmology

Volumn 133, Issue 3, 2002, Pages 393-397

  Wand, Martin ^a   Shields, M Bruce M ^b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; BIMATOPROST; LATANOPROST; LIPID; TRAVOPROST; UNOPROSTONE ISOPROPYL ESTER;

CATARACT EXTRACTION; CLINICAL TRIAL; DRUG TOLERABILITY; EXPERIENCE; EYE INFLAMMATION; EYE SURGERY; HUMAN; LENS CAPSULE; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; REVIEW; RISK ASSESSMENT;

ADRENERGIC AGONISTS; ANTIHYPERTENSIVE AGENTS; CATARACT EXTRACTION; EPINEPHRINE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MACULAR EDEMA, CYSTOID; PROSTAGLANDINS F, SYNTHETIC; RISK FACTORS;

EID: 0036177161     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(01)01412-X     Document Type: Review

References (44)

1. A newly defined vitreous syndrome following cataract surgery interpreted according to recent concepts of the structure of the vitreous
2. Cystoid macular edema and papilledema following cataract extraction. A fluorescein, fundoscopic, and angiographic study
3. Perifoveal vascular leakage and macular oedema after intracapsular cataract extraction
4. Synthesis of the literature on visual acuity and complications following cataract extraction with intraocular lens implantation. Cataract Patient Outcome Research Team
5. Cystoid macular edema after intracapsular and extracapsular cataract extraction with and without an intraocular lens
6. Cystoid macular edema after phacoemulsification: Relationship to blood-aqueous barrier damage and visual acuity
7. Role of the posterior capsule in the aqueous-vitreous barrier in aphakic and pseudophakic eyes
8. Cystoid macular edema after intracapsular and extracapsular cataract extraction with and without an intraocular lens
9. Extracapsular cataract extraction with posterior chamber lens implantation in patients with glaucoma
10. Cystoid macular oedema following cataract extraction in patients with diabetes
11. Chronic cystoid macular edema and predictors of visual acuity
12. Cystoid macular edema after ocular surgery
13. Incidence of cystoid macular edema after retinal detachment surgery and the use of topical indomethacin
14. Secondary surgical and neodymium: YAG laser discussions
15. Long-term followup of Nd: YAG laser posterior capsulotomy
16. Prophylaxis and therapy of aphakic cystoid macular edema
17. Inflammatory mediators in post-operative aphakic and pseudophakic baboon eyes
18. Disruption of the blood-aqueous barrier by residual lens epithelial cells after intraocular lens implantation
19. Synthesis of interleukin-1 and prostaglandin E2 by lens epithelial cells of human cataracts
20. The molecular biology and ocular distribution of prostanoid receptors
21. Prevention of cystoid macular edema after lens extraction by topical indomethycin: III. Radioimmunoassay measurements of prostaglandins in the aqueous during and after lens extraction procedures
22. Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edema. Flurbiprofen-CME Study Group I
23. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine
24. Ketorolac treatment of pseudophakic cystoid macular edema identified more than 24 months after cataract extraction
25. Topical epinephrine in the treatment of the glaucomas
26. Epinephrine maculopathy
27. Cystoid macular edema associated with topically applied epinephrine in aphakic eyes
28. Correlation of epinephrine use and macular edema in aphakic glaucomatous eyes
29. Long-term effects of topically applied epinephrine on the blood-ocular barrier in humans
30. Synthesis of prostaglandin E in rabbit eyes with topically applied epinephrine
31. Indomethacin and the epinephrine-induced breakdown of the blood-ocular barrier in rabbits
32. Latanoprost and cystoid macular edema: Is there a causal relation?
33. Visually significant cystoid macular edema in pseudophakic and aphakic patients with glaucoma receiving latanoprost
34. Latanoprost and cystoid macular edema in high risk aphakic or pseudophakic eyes
35. Latanoprost as a new horizon in the medical management of glaucoma
36. The bioavailability of Xalatan in the human eye
37. Pharmacokinetics of latanoprost in the cynomolgus monkey, 1st communication: Single intravenous, oral or topical administration on the eye
38. Prostaglandin F2α and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species
39. Cystoid macular edema and anterior uveitis associated with latanoprost use
40. Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias
41. Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia
42. Cystoid macular edema associated with ocular hypotensive lipids
43. Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis
44. Keratitis, ulceration, and perforation associated with topical non steroidal anti-inflammatory drugs